Taysha Gene Therapies
TSHA
TSHA
51 hedge funds and large institutions have $475M invested in Taysha Gene Therapies in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+5
Holders Change %
+10.87%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
8
Reduced
9
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$38M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.3M |
3 |
BlackRock
New York
|
+$10.3M |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.35M |
5 |
State Street
Boston,
Massachusetts
|
+$2.92M |
Top Sellers
1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$8.37M |
2 |
Citadel Advisors
Miami,
Florida
|
-$5.56M |
3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$5.27M |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.96M |
5 |
UBS AM
Chicago,
Illinois
|
-$4.48M |